L. Véronèse
Impact in
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Brain Metastases and Treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Melanoma and MAPK Pathways 4
- Fibroblast Growth Factor Research 4
- Protein Degradation and Inhibitors 2
- Chromatin Remodeling and Cancer 2
-
- Lung Cancer Treatments and Mutations 4
- Brain Metastases and Treatment 2
- Co-authors
- Lada Mitchell (3 shared papers)Simone M. Goldinger (2 shared papers)N. Eggmann (2 shared papers)Christian P. Turtschi (2 shared papers)Reinhard Dummer (2 shared papers)Jeannine D. Rinderknecht (2 shared papers)Olivier Michielin (2 shared papers)Paul R. Hilfiker (2 shared papers)
- Journals
- Annals of Oncology (4 papers)npj Precision Oncology (2 papers)Cancer Research (2 papers)Neuro-Oncology (1 paper)ESMO Open (1 paper)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
L. Véronèse
17 papers receiving 659 citations
Peers
Comparison fields: 5 of 53
- Oncology 320
- Pulmonary and Respiratory Medicine 242
- Genetics 66
- Molecular Biology 337
- Cancer Research 60
Countries citing papers authored by L. Véronèse
This map shows the geographic impact of L. Véronèse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Véronèse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Véronèse more than expected).
Fields of papers citing papers by L. Véronèse
This network shows the impact of papers produced by L. Véronèse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Véronèse. The network helps show where L. Véronèse may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Véronèse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 230 | |
| 2 | 2014 | 196 | |
| 3 | 2021 | 138 | |
| 4 | 2018 | 22 | |
| 5 | 2021 | 16 | |
| 6 | 2012 | 12 | |
| 7 | 2017 | 11 | |
| 8 | 2023 | 11 | |
| 9 | 2015 | 9 | |
| 10 | 2020 | 9 | |
| 11 | 1994 | 8 | |
| 12 | 2021 | 6 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2022 | 1 | |
| 17 | 2020 | 1 |
About L. Véronèse
L. Véronèse is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 17 papers that have together received 678 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Lung Cancer Treatments and Mutations (4 papers), Fibroblast Growth Factor Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Protein Degradation and Inhibitors (2 papers), Multiple Myeloma Research and Treatments (2 papers), Chromatin Remodeling and Cancer (2 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Oncology (320 citations), Pulmonary and Respiratory Medicine (242 citations), Genetics (66 citations), Molecular Biology (337 citations) and Cancer Research (60 citations). L. Véronèse has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Lada Mitchell, Simone M. Goldinger, N. Eggmann, Christian P. Turtschi, Reinhard Dummer, Jeannine D. Rinderknecht, Olivier Michielin, Paul R. Hilfiker, Lea Felderer and Matthew Krebs. Their work appears in journals such as Annals of Oncology, npj Precision Oncology, Cancer Research, Neuro-Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.